Aurora Spine Corporation
Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. The company offers interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTR, ZIP LP, and ZIP-51 for patients suffering from degenerative disc diseases. It also provides SOLO, an anterior lumbar inter… Read more
Aurora Spine Corporation (ASAPF) - Net Assets
Latest net assets as of September 2025: $3.83 Million USD
Based on the latest financial reports, Aurora Spine Corporation (ASAPF) has net assets worth $3.83 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($11.69 Million) and total liabilities ($7.86 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $3.83 Million |
| % of Total Assets | 32.78% |
| Annual Growth Rate | 15.02% |
| 5-Year Change | 34.01% |
| 10-Year Change | N/A |
| Growth Volatility | 49.11 |
Aurora Spine Corporation - Net Assets Trend (2017–2024)
This chart illustrates how Aurora Spine Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Aurora Spine Corporation (2017–2024)
The table below shows the annual net assets of Aurora Spine Corporation from 2017 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $4.40 Million | -16.99% |
| 2023-12-31 | $5.30 Million | +22.71% |
| 2022-12-31 | $4.32 Million | -22.49% |
| 2021-12-31 | $5.57 Million | +69.73% |
| 2020-12-31 | $3.28 Million | +85.59% |
| 2019-12-31 | $1.77 Million | -40.23% |
| 2018-12-31 | $2.96 Million | +79.13% |
| 2017-12-31 | $1.65 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Aurora Spine Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 813188600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $31.18 Million | 708.97% |
| Total Equity | $4.40 Million | 100.00% |
Aurora Spine Corporation Competitors by Market Cap
The table below lists competitors of Aurora Spine Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
GreenTree Hospitality Group Ltd
NYSE:GHG
|
$12.90 Million |
|
Ajiya Bhd
KLSE:7609
|
$12.91 Million |
|
Lung Hwa Electronics Co Ltd
TW:2424
|
$12.91 Million |
|
Opus One Resources Inc
V:OOR
|
$12.91 Million |
|
Firetrade Engineering PCL
BK:FTE
|
$12.90 Million |
|
Moksh Ornaments Limited
NSE:MOKSH
|
$12.89 Million |
|
Centrale d'Achat Francaise pour l' Outre Mer
LSE:0HRB
|
$12.89 Million |
|
MeVis Medical Solutions AG
XETRA:M3V
|
$12.89 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Aurora Spine Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 5,297,323 to 4,397,261, a change of -900,062 (-17.0%).
- Net loss of 1,002,609 reduced equity.
- Other factors increased equity by 102,547.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.00 Million | -22.8% |
| Other Changes | $102.55K | +2.33% |
| Total Change | $- | -16.99% |
Book Value vs Market Value Analysis
This analysis compares Aurora Spine Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.92x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 4.86x to 3.92x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | $0.05 | $0.22 | x |
| 2018-12-31 | $0.06 | $0.22 | x |
| 2019-12-31 | $0.04 | $0.22 | x |
| 2020-12-31 | $0.06 | $0.22 | x |
| 2021-12-31 | $0.08 | $0.22 | x |
| 2022-12-31 | $0.06 | $0.22 | x |
| 2023-12-31 | $0.07 | $0.22 | x |
| 2024-12-31 | $0.06 | $0.22 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Aurora Spine Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -22.80%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -5.71%
- • Asset Turnover: 1.50x
- • Equity Multiplier: 2.65x
- Recent ROE (-22.80%) is above the historical average (-43.46%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | -135.67% | -37.41% | 1.13x | 3.20x | $-2.41 Million |
| 2018 | -2.31% | -0.79% | 1.27x | 2.31x | $-364.02K |
| 2019 | -70.94% | -11.25% | 1.67x | 3.77x | $-1.43 Million |
| 2020 | -7.07% | -2.68% | 1.21x | 2.18x | $-560.22K |
| 2021 | -42.36% | -22.37% | 1.00x | 1.90x | $-2.92 Million |
| 2022 | -34.78% | -10.09% | 1.47x | 2.34x | $-1.93 Million |
| 2023 | -31.72% | -11.57% | 1.21x | 2.26x | $-2.21 Million |
| 2024 | -22.80% | -5.71% | 1.50x | 2.65x | $-1.44 Million |
Industry Comparison
This section compares Aurora Spine Corporation's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Aurora Spine Corporation (ASAPF) | $3.83 Million | -135.67% | 2.05x | $12.90 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |